在老鼠的乙烯糖醇诱导的尿病中,ptonide的抗尿质作用
Qiang Wang1, Jinghong Zhang1, Xiaosong Yin1
1Department of Urology, Baoding First Central Hospital, Baoding, China.
Toxicology mechanisms and methods
|June 26, 2024
概括
ptonide有效地防止结石 (结石) 的形成,并减少大鼠的损伤. 这种天然化合物显示出作为当前抗尿石药物的强大替代品的希望.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 尿病是一种常见的全球性泌尿病状况.
- 目前治疗结石的方法存在局限性.
- 需要新的治疗药物.
研究的目的:
- 为了研究ptonide 的抗尿石效应.
- 评估ptonide在预防结石形成和损伤方面的有效性.
- 为了比较ptonide 与标准的抗尿石药物.
主要方法:
- 在雄性Sprague-Dawley大鼠中,尿病被化学诱导.
- 被治疗的老鼠接受了ptonide或cystone (标准药物).
- 测量了脏重量,尿路参数 (pH,体积,蛋白质),离子分泌,抗氧化剂水平和炎症性细胞因子.
主要成果:
- ptonide调节了尿液pH值,减少了蛋白质和增加了尿液量.
- 它改变了,,,,,,肌和尿酸的尿路分泌.
- ptonide增加了抗氧化酶 (SOD,CAT,GPx),减少了氧化应激 (MDA),并减少了炎症.
结论:
- ptonide 显著地阻止了 urolithiasis 的老鼠模型中的结石形成.
- ptonide 保护脏组织免受尿病引起的损伤.
- ptonide显示出作为一种有效的替代抗尿石药物的潜力.
相关概念视频
Renal Drug Excretion: Tubular Secretion
174
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
174
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K


